Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Antonia, SJ
  • Gettinger, S
  • Goldman, J
  • Chow, LQ
  • Juergens, Rosalyn
  • Borghaei, H
  • Brahmer, JR
  • Shen, Y
  • Harbison, C
  • Chen, AC
  • Ready, NE
  • Rizvi, NA

publication date

  • November 2014